Document Detail

Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution.
MedLine Citation:
PMID:  21431988     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Merkel cell carcinoma (MCC) is a cutaneous neuroendocrine neoplasm with propensity for lymphatic spread. The rarity of MCC has limited analysis of factors associated with a positive sentinel lymph node biopsy (SLNB) and survival.
METHODS: Review of a prospective MCC database was performed. Factors associated with SLNB positivity were analyzed. Univariate and multivariate analyses of factors associated with recurrence and survival were performed using the cumulative incidence (CI) function, treating death from other causes as a competing risk.
RESULTS: From 1996 to 2010, a total of 153 patients with localized MCC underwent SLNB, of whom 45 (29%) were positive. Factors associated with SLNB positivity were primary tumor size (25% ≤2 cm vs. 45% >2 cm; P = 0.02) and presence of lymphovascular invasion (LVI) (55% LVI positive vs. 4% LVI negative; P < 0.01). SLNB-positive patients were more likely to receive radiation or chemotherapy (60% vs. 7%, P < 0.01). With median follow-up of 41 months, there were 16 nodal/distant recurrences (10%), 11 deaths from MCC (7%), and 27 death from other causes (18%). The 2-year CIs of recurrence or death from MCC were 12% and 6%, respectively. There was no difference in recurrence or death from MCC between SLNB-positive and -negative patients. The 2-year CIs of recurrence or death from MCC for LVI-positive patients were 30% and 15%, respectively. No LVI-negative patient experienced recurrence of disease or died of MCC.
DISCUSSION: SLNB identifies occult nodal metastases in 29% of patients with localized MCC. Predictors of SLNB positivity are tumor size and presence of lymphovascular invasion (LVI). Patients with SLNB-positive disease are more likely to receive further treatment; however, sentinel lymph node (SLN) status is not associated with recurrence or survival. In contrast, LVI is strongly associated with both recurrence and survival.
Ryan C Fields; Klaus J Busam; Joanne F Chou; Katherine S Panageas; Melissa P Pulitzer; Dennis H Kraus; Mary S Brady; Daniel G Coit
Related Documents :
20435508 - Acute toxicity of three versus two courses of cisplatin for radiochemotherapy of locall...
21457128 - Hepatic non-hodgkin lymphoma and hepatoblastoma complicating ataxia-telangiectasia.
11874068 - A ten-year remission maintained by 6,272 mg (3,920 mg/m2) cumulative dose of cisplatin-...
8996138 - Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus if...
17489988 - Radiotherapy for extramammary paget's disease: histopathological findings after radioth...
3661488 - Phase ii trial of sequential chemotherapy and low-dose radiotherapy in advanced gastric...
Publication Detail:
Type:  Clinical Trial; Journal Article     Date:  2011-03-24
Journal Detail:
Title:  Annals of surgical oncology     Volume:  18     ISSN:  1534-4681     ISO Abbreviation:  Ann. Surg. Oncol.     Publication Date:  2011 Sep 
Date Detail:
Created Date:  2011-08-29     Completed Date:  2012-01-03     Revised Date:  2014-08-20    
Medline Journal Info:
Nlm Unique ID:  9420840     Medline TA:  Ann Surg Oncol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2529-37     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Carcinoma, Merkel Cell / mortality*,  secondary,  surgery
Cohort Studies
Follow-Up Studies
Lymphatic Metastasis
Middle Aged
Neoplasm Recurrence, Local / mortality*,  pathology,  surgery
Neoplasm Staging
Prospective Studies
Sentinel Lymph Node Biopsy
Skin Neoplasms / mortality*,  pathology,  surgery
Survival Rate
Grant Support

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Preoperative Staging of Patients with Liver Metastases of Colorectal Carcinoma. Does PET/CT Really A...
Next Document:  Comparison of isoniazid monoresistant tuberculosis with drug-susceptible tuberculosis and multidrug-...